Vident Investment Advisory’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-23,847
| Closed | -$4.38M | – | 1280 |
|
|
2021
Q2 | $4.38M | Buy |
23,847
+2,145
| +10% | +$394K | 0.13% | 148 |
|
|
2021
Q1 | $3.32M | Buy |
+21,702
| New | +$3.32M | 0.11% | 171 |
|
|
2020
Q4 | – | Sell |
-31,524
| Closed | -$3.61M | – | 936 |
|
|
2020
Q3 | $3.61M | Buy |
31,524
+17,596
| +126% | +$2.01M | 0.18% | 105 |
|
|
2020
Q2 | $1.56M | Buy |
13,928
+7,296
| +110% | +$819K | 0.08% | 293 |
|
|
2020
Q1 | $596K | Buy |
+6,632
| New | +$596K | 0.04% | 532 |
|
|
2018
Q2 | – | Sell |
-3,780
| Closed | -$416K | – | 997 |
|
|
2018
Q1 | $416K | Sell |
3,780
-4,302
| -53% | -$473K | 0.02% | 690 |
|
|
2017
Q4 | $966K | Buy |
8,082
+17
| +0.2% | +$2.03K | 0.04% | 382 |
|
|
2017
Q3 | $1.13M | Buy |
+8,065
| New | +$1.13M | 0.06% | 350 |
|
|
2015
Q3 | – | Sell |
-19
| Closed | -$3K | – | 1177 |
|
|
2015
Q2 | $3K | Buy |
+19
| New | +$3K | ﹤0.01% | 1054 |
|